Precision Biosciences (DTIL) Receivables (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Receivables came in at $4.0 million in Q1 2026, up 99900.0% year-on-year from N/an in Q1 2025, and up 99900.0% on a QoQ basis from $4000.0 in Q3 2025.
Precision Biosciences (DTIL) Receivables (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Receivables data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Receivables rose 99900.0% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 99900.0% increase from a year earlier, with the FY2024 full-year figure at $229000.0, down 74.58% from the prior year.
- Receivables for Q1 2026 stood at $4.0 million, up from $4000.0 in the prior quarter.
- Over the last five years, Receivables for DTIL reached as high as $50.5 million in Q2 2022 and fell as low as $4000.0 in Q1 2025.
- Historically, Receivables has averaged $4.2 million across 5 years, with a median of $652000.0 in 2023.
- Across the five-year window, Receivables sank 98.97% in 2025 and soared 99900.0% in 2026, its largest moves.
- Year by year, Receivables stood at $720000.0 in 2022, then gained by 25.14% to $901000.0 in 2023, then plunged by 74.58% to $229000.0 in 2024, then tumbled by 98.25% to $4000.0 in 2025, then surged by 99900.0% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $4.0 million in Q1 2026, $4000.0 in Q3 2025, and $4000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Sep 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 229,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 901,000.00 |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 652,000.00 |
| Mar 31, 2023 | 694,000.00 |
| Dec 31, 2022 | 720,000.00 |
| Sep 30, 2022 | 715,000.00 |
| Jun 30, 2022 | 50.51 Mn |
| Mar 31, 2022 | 488,000.00 |
| Dec 31, 2021 | 488,000.00 |
| Sep 30, 2021 | 488,000.00 |
| Jun 30, 2021 | 488,000.00 |
| Mar 31, 2021 | 19.26 Mn |
| Dec 31, 2020 | 10.00 Mn |